slides · global inventory
Table Data
Tool collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 16,285
Current window 8,101-8,130
Pages 543
Rows per page 30
Tool
8,101-8,130 of 16,285
18
The table includes a breakdown of specific adjustments (A-E) with corresponding commentary on the right.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
19
The table tracks debt components, total debt, net debt, and leverage ratios (Total Debt/EBITDA and Net Debt/EBITDA) over time.GMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
20
GMS | Results Presentation Deck | 20 slidesGMS | Results Presentation Deck | 20 slides · GMS
Conference presentation Investor relations Beat · Visualization1 hit
07
The slide explains the transition to IFRS 17 and how 'adjusted performance' metrics are calculated.HSBC | Investor Event Presentation Deck | 10 slides · HSBC
Conference presentation Investor relations 1 hit
18
The slide compares cytokine inhibition efficacy in Healthy Subjects (MAD3), AD patients, and HS patients using two different stimulation methods (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
39
Includes a disclaimer/footnote regarding patient population and MYD88 mutation status.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
42
Includes a table of prevalence/incidence for specific oncology indications and a biological pathway diagram.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
44
The slide outlines a standard oncology clinical trial design (3+3 or similar dose escalation) followed by cohort expansion.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
46
Includes a line chart for PK profiles and a table for PK parameters (Cmax, AUClast, Vd, CL, t1/2).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations 1 hit
30
Limoneira | Investor Day Presentation Deck | 65 slidesLimoneira | Investor Day Presentation Deck | 65 slides · Limoneira
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a color-coded table structure to map commitments to specific programs and initiatives.LVMH | ESG Presentation Deck | 33 slides · LVMH
Conference presentation Investor relations Beat · WhyLoop · Cost Of Inaction1 hit
35
The table compares 5-year total economic benefit and management costs for MAIN vs various peer group quartiles.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
36
The table compares internal vs external management structures and their associated costs relative to economic benefits generated over a 5-year period.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations Beat · TeamLoop · Cost Of Inaction1 hit
74
Includes detailed footnotes regarding data sources and portfolio status as of March 31, 2023.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
86
The slide highlights two primary valuation methods: market-comparable/historical cash flow and DCF.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
93
The slide uses color-coded labels (blue vs orange) to distinguish between Elgin-manufactured parts and third-party parts, as defined in the key.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
95
Includes a technical diagram of a vehicle suspension system with labeled parts.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
105
The table uses a matrix structure to compare performance metrics over time and across business segments.Main Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
111
Main Street Capital | Investor Day Presentation Deck | 155 slidesMain Street Capital | Investor Day Presentation Deck | 155 slides · Main Street Capital Corporation
Conference presentation Investor relations 1 hit
15
Includes a citation to a published study in the journal 'Cancers' and collaboration with Université de Sherbrooke.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
21
Includes unaudited financial results and balance sheet data.Mainz Biomed NV | Investor Presentation Deck | 25 slides · Mainz Biomed
Pitch deck Investor relations 1 hit
23
Maris-Tech | Investor Presentation Deck | 28 slidesMaris-Tech | Investor Presentation Deck | 28 slides · Maris-Tech
Deck Investor relations Beat · FinancialsLoop · Why Now1 hit
13
The slide uses a table to establish historical credibility for the company's therapeutic approach.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
17
The slide uses a timeline diagram to illustrate the study flow from randomization to follow-up.MindMed | Investor Presentation Deck | 36 slides · MindMed
Pitch deck Investor relations 1 hit
07
The slide uses a contrast-based layout to highlight performance failures.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · AgitateLoop · Cost Of Inaction1 hit
11
Uses a 'Claim vs Reality' framework to discredit competitors' M&A strategies.Nano Dimension | Mergers and Acquisitions Presentation Deck | 12 slides · Nano Dimension
Activist deck Investment bank Beat · Solution1 hit
05
Includes non-IFRS adjustments and footnotes regarding reconciliation and expense exclusions.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Current StateLoop · Zoom In1 hit
16
Includes reconciliation for EBITDA, Adjusted EBITDA, Adjusted Gross Profit, and Net Cash used in operations.Nano Dimension | Results Presentation Deck | 18 slides · Nano Dimension
Conference presentation Investor relations Beat · Conclusion1 hit